Orthofix Medical (OFIX) Work In Process (2011 - 2026)

Orthofix Medical has disclosed Work In Process across 16 years of filings, most recently posting $65.2 million for Q1 2026.

• Quarterly Work In Process rose 14.84% year-over-year to $65.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $65.2 million (up 14.84% YoY) and the FY2025 annual result came in at $63.3 million, up 11.13% from the prior year.
• Work In Process improved to $65.2 million in Q1 2026, from $63.3 million in the prior quarter.
• Over five years, Work In Process peaked at $65.2 million in Q1 2026 and troughed at $14.5 million in Q1 2022.
• A 5-year average of $48.6 million and a median of $56.8 million in 2025 frame the typical range for Work In Process.
• Annual changes were most pronounced in 2022 — Work In Process declined 5.48% — and 2023, when it surged 303.9%.
• Tracing OFIX's Work In Process over 5 years: stood at $19.2 million in 2022, then surged by 178.08% to $53.5 million in 2023, then climbed by 6.37% to $56.9 million in 2024, then increased by 11.13% to $63.3 million in 2025, then advanced by 3.07% to $65.2 million in 2026.
• Business Quant data shows OFIX's Work In Process at $65.2 million in Q1 2026, $63.3 million in Q4 2025, and $61.0 million in Q3 2025.